Factor structure of social fears: The Liebowitz Social Anxiety Scale

Journal of Anxiety Disorders

Volumn 13, Issue 3, 1999, Pages 253-270

  Safren, Steven A ^a   Heimberg, Richard G ^b   Horner, Kelly J ^c   Juster, Harlan R ^c   Schneier, Franklin R ^d   Liebowitz, Michael R ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; PHENELZINE;

ADULT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR; CLINICAL TRIAL; COGNITIVE THERAPY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FACTORIAL ANALYSIS; FEAR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SOCIAL INTERACTION; SOCIAL PHOBIA;

ADOLESCENT; ADULT; COGNITIVE THERAPY; FEAR; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; PHOBIC DISORDERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS;

EID: 0033019654     PISSN: 08876185     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-6185(99)00003-1     Document Type: Article

References (45)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 3rd ed:1980;Author, Washington, DC.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 3rd ed., rev. 1987;Author, Washington, DC.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 4th ed:1994;Author, Washington, DC.
4. Anderson J.G. Structural equation models in the social and behavioral sciences. Model building Child Development. 58:1987;49-64.
5. Brown E.J., Heimberg R.G., Juster H.R. Social phobia subtype and avoidant personality disorder. Effect on severity of social phobia, impairment, and outcome of cognitive-behavioral treatment Behavior Therapy. 26:1995;467-486.
6. Brown E.J., Turovsky J., Heimberg R.G., Juster H.R., Brown T.A., Barlow D.H. Validation of the Social Interaction Anxiety Scale and the Social Phobia Scale across the anxiety disorders. Psychological Assessment. 9:1997;21-27.
7. Cattell R.B. The meaning and strategic use of factor analysis. Cattell R.B. Handbook of multivariate experimental psychology. 1966;174-243 Rand McNally, Chicago.
8. DiNardo P.A., Barlow D.H. The Anxiety Disorders Interview Schedule, Revised (ADIS-R). 1988;Graywind Publications, Albany, NY.
9. DiNardo P.A., Brown T.A., Barlow D.H. Anxiety Disorders Interview Schedule for DSM-IV. Lifetime version (ADIS-IV-L):1994;Graywind Publications, Albany, NY.
10. DiNardo P.A., Moras K., Barlow D.H., Rapee R.M., Brown T.A. Reliability of DSM-III-R anxiety disorder categories. Using the Anxiety Disorders Interview Schedule-Revised Archives of General Psychiatry. 50:1993;251-256.
11. Floyd F.J., Widaman K.F. Factor analysis in the development and refinement of clinical assessment instruments. Psychological Assessment. 7:1995;286-299.
12. Gelernter C.S., Stein M.B., Tancer M.E., Uhde T.W. An examination of syndromal validity and diagnostic subtypes in social phobia and panic disorder. Journal of Clinical Psychiatry. 53:1992;23-27.
13. Gorsuch R.L. Factor analysis. 2nd ed:1983;Lawrence Erlbaum Associates, Hillsdale, NJ.
14. Heimberg R.G., Holt C.S., Schneier F.R., Spitzer R.L., Liebowitz M.R. The issue of subtypes in the diagnosis of social phobia. Journal of Anxiety Disorders. 7:1993;249-269.
15. Heimberg R.G., Hope D.A., Dodge C.S., Becker R.E. DSM-III-R subtypes of social phobia. Comparison of generalized social phobics and public speaking phobics Journal of Nervous and Mental Disease. 173:1990;172-179.
16. Heimberg R.G., Horner K.J., Juster H.R., Safren S.A., Brown E.J., Schneier F.R., Liebowitz M.R. Psychometric properties of the Liebowitz Social Anxiety Scale. Psychological Medicine. 29:1999;199-212.
17. Heimberg R.G., Liebowitz M.R., Hope D.A., Schneier F.R., Holt C.S., Welkowitz L., Juster H.R., Campeas R., Bruch M.A., Cloitre M., Fallon B., Klein D.F. Cognitive-behavioral group therapy versus phenelzine in social phobia. 12-week outcome Archives of General Psychiatry. 55:1988;1133-1141.
18. Heimberg R.G., Mueller G.P., Holt C.S., Hope D.A., Liebowitz M.R. Assessment of anxiety in social interaction and being observed by others. The Social Interaction Anxiety Scale and the Social Phobia Scale Behavior Therapy. 23:1992;53-75.
19. Herbert J.D., Hope D.A., Bellack A.S. Validity of the distinction between generalized social phobia and avoidant personality disorder. Journal of Abnormal Psychology. 101:1992;332-339.
20. Holt C.S., Heimberg R.G., Hope D.A. Avoidant personality disorder and the generalized subtype of social phobia. Journal of Abnormal Psychology. 101:1992;318-325.
21. Holt C.S., Heimberg R.G., Hope D.A., Liebowitz M.R. Situational domains of social phobia. Journal of Anxiety Disorders. 6:1992;63-77.
22. Jöreskog K., Sörbom D. LISREL 8. A guide to the program and applications:1993;Scientific Software, Chicago.
23. Juster H.R., Heimberg R.G., Holt C.S. Social phobia. Diagnostic issues and review of cognitive-behavioral treatment strategies Hersen M., Eisler R.M., Miller P.M. Progress in behavior modification (Vol. 2). 1996;74-98 Sycamore Publising Company, Sycamore, IL.
24. Leary M.R. Social Anxiousness. The construct and its measurement Journal of Personality Assessment. 47:1983;66-75.
25. Leung A.W., Heimberg R.G. Homework compliance, perceptions of control, and outcome of cognitive-behavioral treatment of social phobia. Behaviour Research and Therapy. 34:1996;423-432.
26. Liebowitz M.R. Social phobia. Modern Problems of Pharmacopsychiatry. 22:1987;141-173.
27. Liebowitz M.R., Schneier F.R., Campeas R., Hollander E., Hatterer J., Fyer A., Gorman J., Papp L., Davies S., Gully R., Klein D.F. Phenelzine vs atenolol in social phobia. A placebo-controlled comparison Archives of General Psychiatry. 49:1992;290-300.
28. Lott M., Greist J.H., Jefferson J.W., Kobak K.A., Katzelnick D.J., Katz R.J., Schaettle S.C. Brofaromine for social phobia. A multicenter, placebo-controlled, double-blind study Journal of Clinical Psychopharmacology. 17:1997;255-260.
29. Mannuzza S., Fyer A.J., Klein D.F., Endicott J. Schedule for Affective Disorders and Schitzophrenia-Lifetime version modified for the study of anxiety disorders (SADS-LA). Rationale and conceptual development Journal of Psychiatric Research. 20:1986;317-325.
30. Mannuzza S., Fyer A.J., Martin L.Y., Gallops M.S., Endicott J., Gorman J., Liebowitz M.R., Klein D.F. Reliability of anxiety assessment. I. Diagnostic agreement Archives of General Psychiatry. 46:1989;1093-1101.
31. Mannuzza S., Schneier F.R., Chapman T.F., Liebowitz M.R., Klein D.F., Fyer A.J. Generalized social phobia. Reliability and validity Archives of General Psychiatry. 52:1995;230-237.
32. Marks I.M., Mathews A.M. Brief standard self-rating for phobic patients. Behaviour Research and Therapy. 17:1979;263-267.
33. Mattick R.P., Clarke J.C. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behaviour Research and Therapy. 36:1998;455-470.
34. McNeil D.W., Ries B.J., Turk C.L. Behavioral assessment. Self-report, physiology, and overt behavior Heimberg R.G., Liebowitz M.R., Hope D.A., Schneier F.R. Social phobia. Diagnosis, assessment, and treatment:1995;202-231 Guilford Press, New York.
35. Munjack D.J., Burns J., Baltazar P.L., Brown R., Leonard M., Nagy R., Koek R., Crocker B., Schafer S. A pilot study of buspirone in the treatment of social phobia. Journal of Anxiety Disorders. 5:1991;87-98.
36. Noyes R., Moroz G., Davidson J.R.T., Liebowitz M.R., Davidson A., Siegel J., Bell J., Cain J.W., Curlik S.M., Kent T.A., Lydiard B., Mallinger A.G., Pollack M.H., Rapaport M., Rasmussen S.A., Hedges D., Schweizer E., Uhlenhuth E.H. Moclobemide in social phobia. A controlled dose-response trial Journal of Clinical Psychopharmacology. 17:1997;247-254.
37. Reich J.R., Yates W. A pilot study of treatment of social phobia with alprazolam. American Journal of Psychiatry. 145:1988;590-594.
38. Safren S.A., Heimberg R.G., Brown E.J., Holle C. Quality of life in patients with social phobia. Depression and Anxiety. 4:1997;126-133.
39. Safren S.A., Heimberg R.G., Juster H.R. Client expectancies and their relationship to pretreatment symtomatology and outcome of cognitive-behavioral group treatment for social phobia. Journal of Consulting and Clinical Psychology. 65:1997;694-698.
40. Safren S.A., Turk C.L., Heimberg R.G. Factor structure of the Social Interaction Anxiety Scale and the Social Phobia Scale. Behaviour Research and Therapy. 36:1998;443-453.
41. Schneier F.R., Goetz D., Campeas R., Marshall R., Fallon B., Liebowitz M.R. Placebo-controlled trial of moclobemide in social phobia. British Journal of Psychiatry. 172:1998;70-77.
42. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. The Structured Clinical Interview for DSM-III-R (SCID). I. History, rationale, and description Archives of General Psychiatry. 49:1992;624-629.
43. Turner S.M., Beidel D.C., Townsley R.M. Social phobia. A comparison of specific and generalized subtypes and avoidant personality disorder Journal of Abnormal Psychology. 101:1992;326-331.
44. Versiani M., Nardi A.E., Mundim F.D., Alves A.B., Liebowitz M.R., Amrein R. Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine British Journal of Psychiatry. 161:1992;353-360.
45. Watson D., Friend R. Measurement of social evaluative anxiety. Journal of Consulting and Clinical Psychology. 33:1969;448-457.